GNRH1 and prostate carcinoma: Similarly, Nishiyama et al. studied 49 patients with prostate cancer who received ADT in a manner similar to ours, GnRH + AA or orchiectomy + AA, for six months and found a slight, but significant, increase in FBG levels over the course of the study.